BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bustamante A, Mancha F, Macher HC, García-Berrocoso T, Giralt D, Ribó M, Guerrero JM, Montaner J. Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis. J Circ Biomark 2016;5:1849454416668791. [PMID: 28936264 DOI: 10.1177/1849454416668791] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Fathima N, Manorenj S, Vishwakarma SK, Khan AA. Role of cell-free DNA for predicting incidence and outcome of patients with ischemic stroke. World J Neurol 2022; 8(1): 1-9 [DOI: 10.5316/wjn.v8.i1.1] [Reference Citation Analysis]
2 Fathima N, Manorenj S, Vishwakarma SK, Khan AA. Cell-free mitochondrial DNA quantification in ischemic stroke patients for non-invasive and real-time monitoring of disease status. World J Transl Med 2022; 10(2): 14-28 [DOI: 10.5528/wjtm.v10.i2.14] [Reference Citation Analysis]
3 Liu AP, Northcott PA, Robinson GW, Gajjar A. Circulating tumor DNA profiling for childhood brain tumors: Technical challenges and evidence for utility. Lab Invest 2022;102:134-42. [PMID: 34934181 DOI: 10.1038/s41374-021-00719-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Guo T, Xi Z, Qiu H, Wang Y, Zheng J, Dou K, Xu B, Qiao S, Yang W, Gao R. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention. Ann Med 2021;53:2215-24. [PMID: 34791980 DOI: 10.1080/07853890.2021.2004321] [Reference Citation Analysis]
5 Cuadrat RRC, Kratzer A, Arnal HG, Wreczycka K, Blume A, Ebenal V, Mauno T, Osberg B, Moobed M, Hartung J, Seppelt C, Meteva D, Haghikia A, Leistner D, Landmesser U, Akalin A. Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation.. [DOI: 10.1101/2021.11.05.21265870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Karasawa S, Nakada TA, Sato M, Miyasho T, Shimada T, Oshima T, Suda K, Shinozaki K, Oda S. Early Elevation of Cell-free DNA After Acute Mesenteric Ischemia in Rats. J Surg Res 2021;269:28-35. [PMID: 34517186 DOI: 10.1016/j.jss.2021.07.020] [Reference Citation Analysis]
7 Choi YH, Laaker C, Hsu M, Cismaru P, Sandor M, Fabry Z. Molecular Mechanisms of Neuroimmune Crosstalk in the Pathogenesis of Stroke. Int J Mol Sci 2021;22:9486. [PMID: 34502395 DOI: 10.3390/ijms22179486] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
8 Zhang S, Cao Y, Du J, Liu H, Chen X, Li M, Xiang M, Wang C, Wu X, Liu L, Wang C, Wu Y, Li Z, Fang S, Shi J, Wang L. Neutrophil extracellular traps contribute to tissue plasminogen activator resistance in acute ischemic stroke. FASEB J 2021;35:e21835. [PMID: 34449927 DOI: 10.1096/fj.202100471RR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Orbán-Kálmándi R, Szegedi I, Sarkady F, Fekete I, Fekete K, Vasas N, Berényi E, Csiba L, Bagoly Z. A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis. Sci Rep 2021;11:12713. [PMID: 34135389 DOI: 10.1038/s41598-021-92041-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wijerathne H, Witek MA, Baird AE, Soper SA. Liquid biopsy markers for stroke diagnosis. Expert Rev Mol Diagn 2020;20:771-88. [PMID: 32500751 DOI: 10.1080/14737159.2020.1777859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Vajpeyee A, Wijatmiko T, Vajpeyee M, Taywade O, Pandey S, Chauhan PS. Clinical Usefulness of Cell-Free DNA as a Prognostic Marker in Acute Ischemic Stroke. Neurologist 2020;25:11-3. [PMID: 31876653 DOI: 10.1097/NRL.0000000000000249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
12 Chin RI, Chen K, Usmani A, Chua C, Harris PK, Binkley MS, Azad TD, Dudley JC, Chaudhuri AA. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). Mol Diagn Ther 2019;23:311-31. [PMID: 30941670 DOI: 10.1007/s40291-019-00390-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 61] [Article Influence: 23.7] [Reference Citation Analysis]
13 McGuire AL, Hughesman CB, McConechy MK, Melosky B, Lam S, Myers R, Yee J, Tang E, Yip S. Optimizing molecular residual disease detection using liquid biopsy postoperatively in early stage lung cancer. Lung Cancer Manag 2020;9:LMT24. [PMID: 32346401 DOI: 10.2217/lmt-2019-0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Benincasa G, Mansueto G, Napoli C. Fluid-based assays and precision medicine of cardiovascular diseases: the ‘hope’ for Pandora’s box? J Clin Pathol 2019;72:785-99. [DOI: 10.1136/jclinpath-2019-206178] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
15 Saand AR, Yu F, Chen J, Chou SH. Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target? J Cereb Blood Flow Metab 2019;39:959-88. [PMID: 30961425 DOI: 10.1177/0271678X19841443] [Cited by in Crossref: 95] [Cited by in F6Publishing: 77] [Article Influence: 23.8] [Reference Citation Analysis]
16 Regner A, Meirelles LDS, Ikuta N, Cecchini A, Simon D. Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev Mol Diagn 2018;18:925-38. [PMID: 30307786 DOI: 10.1080/14737159.2018.1535904] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
17 Stewart CM, Kothari PD, Mouliere F, Mair R, Somnay S, Benayed R, Zehir A, Weigelt B, Dawson SJ, Arcila ME, Berger MF, Tsui DW. The value of cell-free DNA for molecular pathology. J Pathol 2018;244:616-27. [PMID: 29380875 DOI: 10.1002/path.5048] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 14.4] [Reference Citation Analysis]
18 Vajpeyee A, Wijatmiko T, Vajpeyee M, Taywade O. Cell free DNA: A Novel Predictor of Neurological Outcome after Intravenous Thrombolysis and/or Mechanical Thrombectomy in Acute Ischemic Stroke Patients. Neurointervention 2018;13:13-9. [PMID: 29535894 DOI: 10.5469/neuroint.2018.13.1.13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
19 Glebova KV, Veiko NN, Nikonov AA, Porokhovnik LN, Kostuyk SV. Cell-free DNA as a biomarker in stroke: Current status, problems and perspectives. Crit Rev Clin Lab Sci 2018;55:55-70. [PMID: 29303618 DOI: 10.1080/10408363.2017.1420032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]